Childhood Cancer Survivors Show Sustained Benefit From Common ADHD Medication - Drugs.com MedNews

Links shared publicly online about this topic.

  • 871
    total visits

Childhood Cancer Survivors Show Sustained Benefit From Common ADHD Medication - Drugs.com MedNews

drugs.com

Trial led by St. Jude Children s Research Hospital investigators finds medication restores sustained attention of many young survivors work begins on new strate

View full resource at drugs.com

Tags: Cancer, ADHD, ADHD Medication, Drug, Hospital, Children's Health, Hospitals

  • Share

Most Recently Shared on September 15, 2010 at 9:12 pm By:

Drugs_Devices Drugs and Devices OW

Childhood Cancer Survivors Show Sustained Benefit From Common ADHD Medication:           Trial led by St. Jud... http://bit.ly/dh563j #drug

2 years ago...

Childhood cancer survivors show sustained benefit from common ADHD medication

labspaces.net — “A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital investigators.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on September 14, 2010 at 4:31 pm By:

LabSpaces Brian Krueger Health News

Childhood cancer survivors show sustained benefit from common ADHD medication - http://is.gd/fat4X

2 years ago...

Childhood cancer survivors show sustained benefit from common ADHD medication http://bit.ly/aAH9dW #adhd #add

sciencedaily.com — “Childhood cancer survivors show sustained benefit from common ADHD medication http://bit.ly/aAH9dW #adhd #addView full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on September 14, 2010 at 4:07 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Childhood cancer survivors show sustained benefit from common ADHD medication http://bit.ly/aAH9dW #adhd #add

2 years ago...

Childhood cancer survivors show sustained benefit from common ADHD medication

physorg.com — “A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital investigators.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on September 13, 2010 at 8:48 pm By:

physorg_health PhysOrg Health News Health News

Childhood cancer survivors show sustained benefit from common ADHD medication http://tw.physorg.com/203614965

2 years ago...

Advertisement